Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01016
|
|||||
| Drug Name |
Tiagabine
|
|||||
| Synonyms |
Gabitril; (-)-(R)-1-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)nipecotic acid; (3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]piperidine-3-carboxylic acid; (3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid; (R)-1-(4,4-Bis(3-methylthiophen-2-yl)but-3-en-1-yl)piperidine-3-carboxylic acid; (R)-Tiagabine; 115103-54-3; A-70569-1; ABBOTT-70569-1; ABT-569; Abbott-70569; CHEBI:9586; CHEMBL1027; Gabatril; Gabitril; Gabitril (TN); N-(4,4-di(3-methylthien-2-yl)but-3-enyl)nipecotic acid; NO 329; NO-328; NO-329; Tiagabina; Tiagabina [INN-Spanish]; Tiagabina [INN-Spanish];Tiagabine (INN); Tiagabine (INN); Tiagabine [INN:BAN]; Tiagabine [INN]; Tiagabinum; Tiagabinum [INN-Latin]; UNII-Z80I64HMNP; Z80I64HMNP; [3H]tiagabine; tiagabine
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Anticonvulsants
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C20H25NO2S2
|
|||||
| Canonical SMILES |
CC1=C(SC=C1)C(=CCCN2CCCC(C2)C(=O)O)C3=C(C=CS3)C
|
|||||
| InChI |
InChI=1S/C20H25NO2S2/c1-14-7-11-24-18(14)17(19-15(2)8-12-25-19)6-4-10-21-9-3-5-16(13-21)20(22)23/h6-8,11-12,16H,3-5,9-10,13H2,1-2H3,(H,22,23)/t16-/m1/s1
|
|||||
| InChIKey |
PBJUNZJWGZTSKL-MRXNPFEDSA-N
|
|||||
| CAS Number |
CAS 115103-54-3
|
|||||
| Pharmaceutical Properties | Molecular Weight | 375.6 | Topological Polar Surface Area | 97 | ||
| Heavy Atom Count | 25 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
2.7
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.